![]() |
|
|
1 Laboratory of Clinical Science, National Institute of Mental Health, National institutes of Health, Bethesda, Maryland
After the intravenous administration of H3-norepinephrine, it was taken up by the heart and slowly released over a period of days. Long-acting monoamine oxidase inhibitors blocked the slow release of H3-norepinephrine. Long-acting and short-acting monoamine oxidase inhibitors blocked the releasing action of reserpine on H3-norepinephrine in the heart. On the basis of these observations it is proposed that monoamine oxidase inhibitors elevated the catecholamine concentration in certain tissues by blocking the release of the hormone from its binding site.
Submitted on May 11, 1961
This article has been cited by other articles:
![]() |
J. J. Schildkraut, P. R. Draskoczy, and P. S. Lo Norepinephrine Pools in Rat Brain: Differences in Turnover Rates and Pathways of Metabolism Science, May 7, 1971; 172(3983): 587 - 589. [Abstract] [PDF] |
||||
![]() |
G. K. Aghajanian, A. W. Graham, and M. H. Sheard Serotonin-Containing Neurons in Brain: Depression of Firing by Monoamine Oxidase Inhibitors Science, September 11, 1970; 169(3950): 1100 - 1102. [Abstract] [PDF] |
||||